Yuhan (XKRX:000100) Total Liabilities : ₩712,584 Mil (As of Mar. 2024)

View and export this data going back to 1962. Start your Free Trial

What is Yuhan Total Liabilities?

Yuhan's Total Liabilities for the quarter that ended in Mar. 2024 was ₩712,584 Mil.

Yuhan's quarterly Total Liabilities increased from Sep. 2023 (₩635,532.63 Mil) to Dec. 2023 (₩712,337.88 Mil) and increased from Dec. 2023 (₩712,337.88 Mil) to Mar. 2024 (₩712,583.97 Mil).

Yuhan's annual Total Liabilities declined from Dec. 2021 (₩527,922.72 Mil) to Dec. 2022 (₩464,921.70 Mil) but then increased from Dec. 2022 (₩464,921.70 Mil) to Dec. 2023 (₩712,337.88 Mil).

Yuhan Total Liabilities Historical Data

The historical data trend for Yuhan's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yuhan Total Liabilities Chart

Yuhan Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

467,208.89

547,019.91

527,922.72

464,921.70

712,337.88

Yuhan Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															494,289.26	521,821.54	635,532.63	712,337.88	712,583.97

Yuhan Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Yuhan's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	583192.369	+	(62390.14	+	64720.259
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	2035.11)
	=	712,338

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	2814070.522	-	2101732.643
	=	712,338

Yuhan's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	562112.382	+	(78650.762	+	69496.524
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	2324.303)
	=	712,584

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	2801252.649	-	2088668.678
	=	712,584

Yuhan Total Liabilities Related Terms

Thank you for viewing the detailed overview of Yuhan's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Yuhan (XKRX:000100) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yuhan Corp (XKRX:000100) » Definitions » Total Liabilities

Traded in Other Exchanges

000105:Korea

Address

74, Noryangjin-ro, Dongjak-gu, Seoul, KOR

Website

http://www.yuhan.co.kr

Yuhan Corp is a pharmaceutical company. The core business of the company is classified as primary and specialty care, dietary supplement, household and animal care, and contract manufacturing of active pharmaceutical ingredients. Yuhan offers one-stop custom synthesis services from research and development to commercial production of active pharmaceutical products (APIs) and intermediates for the following disease treatments: antivirals (HCV and HIV), antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds for international markets.

Yuhan (XKRX:000100) Headlines

No Headlines